Himachandana Atluri

Hematology | Oncology

675 N St Clair St Ste 21-100
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Targeted triplet therapies incorporating FLT3 or IDH inhibitors: ready for prime time?

Targeted triplet therapies incorporating FLT3 or IDH inhibitors: ready for prime time?

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Germline predispositions to myeloid malignancies: Across the lifespan.

Germline predispositions to myeloid malignancies: Across the lifespan.

Journal: Seminars in hematology

Published: August 05, 2025

Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With KMT2A Rearrangements Treated With Immunotherapy-Based Regimens.

Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With KMT2A Rearrangements Treated With Immunotherapy-Based Regimens.

Journal: American journal of hematology

Published: May 31, 2025

Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trial.

Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trial.

Journal: Cancer

Published: December 12, 2024

Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report.

Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report.

Journal: Leukemia research reports

Published: July 17, 2024

A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome Mapping.

A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome Mapping.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 21, 2024

Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.

Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.

Journal: Current hematologic malignancy reports

Published: September 24, 2022

A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.

A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.

Journal: Neuro-oncology practice

Published: May 23, 2022

Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia.

Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia.

Journal: Therapeutic advances in hematology

Published: December 21, 2021

Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting.

Risk factors for mortality and multidrug resistance in pulmonary tuberculosis in Guatemala: A retrospective analysis of mandatory reporting.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases

Published: December 01, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026